ST5 Positively Regulates Osteoclastogenesis via Src/Syk/Calcium Signaling Pathways
Open Access
- 1 November 2019
- journal article
- research article
- Published by Korean Society for Molecular and Cellular Biology in Molecules and Cells
- Vol. 42 (11) , 810-819
Abstract
For physiological or pathological understanding of bone disease caused by abnormal behavior of osteoclasts (OCs), functional studies of molecules that regulate the generation and action of OCs are required. In a microarray approach, we found the suppression of tumorigenicity 5 (ST5) gene is upregulated by receptor activator of nuclear factor-κB ligand (RANKL), the OC differentiation factor. Although the roles of ST5 in cancer and β-cells have been reported, the function of ST5 in bone cells has not yet been investigated. Knockdown of ST5 by siRNA reduced OC differentiation from primary precursors. Moreover, ST5 downregulation decreased expression of NFATc1, a key transcription factor for osteoclastogenesis. In contrast, overexpression of ST5 resulted in the opposite phenotype of ST5 knockdown. In immunocytochemistry experiments, the ST5 protein is colocalized with Src in RANKL-committed cells. In addition, ST5 enhanced activation of Src and Syk, a Src substrate, in response to RANKL. ST5 reduction caused a decrease in RANKL-evoked calcium oscillation and inhibited translocation of NFATc1 into the nucleus. Taken together, these findings provide the first evidence of ST5 involvement in positive regulation of osteoclastogenesis via Src/Syk/calcium signaling.Keywords
This publication has 41 references indexed in Scilit:
- DENND2B activates Rab13 at the leading edge of migrating cells and promotes metastatic behaviorJournal of Cell Biology, 2015
- OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and miceJournal of Clinical Investigation, 2011
- The Tyrosine Kinase Activity of c-Src Regulates Actin Dynamics and Organization of Podosomes in OsteoclastsMolecular Biology of the Cell, 2008
- Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomyAutoimmunity, 2008
- Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleusBMC Cell Biology, 2007
- Autoamplification of NFATc1 expression determines its essential role in bone homeostasisJournal of Experimental Medicine, 2005
- Src kinase activation by direct interaction with the integrin β cytoplasmic domainProceedings of the National Academy of Sciences, 2003
- Osteoclast differentiation and activationNature, 2003
- Activation of NF-κB by RANK Requires Tumor Necrosis Factor Receptor-associated Factor (TRAF) 6 and NF-κB-inducing KinaseJournal of Biological Chemistry, 1999
- Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel p130Cas-related protein, Sin.Genes & Development, 1996